Ambulatory blood pressure monitoring in daily clinical practice - the Spanish ABPM Registry experience

European Journal of Clinical Investigation

Volumn 46, Issue 1, 2016, Pages 92-98

  Gorostidi, Manuel ^a   Banegas, José R ^b   de la Sierra, Alejandro ^c   Vinyoles, Ernest ^c   Segura, Julián ^d   Ruilope, Luis M ^d  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Ambulatory blood pressure measurement; Blood pressure; Blood pressure measurement; Hypertension; Masked hypertension; White coat hypertension

Indexed keywords

BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CLINICAL PRACTICE; HUMAN; MASKED HYPERTENSION; PRIORITY JOURNAL; REGISTER; REVIEW; SPAIN; WHITE COAT HYPERTENSION;

ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE MONITORING, AMBULATORY; HUMANS; MASKED HYPERTENSION; REGISTRIES; SPAIN; WHITE COAT HYPERTENSION;

EID: 84955179104     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12565     Document Type: Review

References (35)

1. Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013;31:1281-357.
2. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014;311:507-20.
3. Weber MA, Schiffrin EL, White WB, Mann S, Lindholm LH, Kenerson JG et al. Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension. J Hypertens 2014;32:3-15.
4. Banegas JR, Graciani A, de la Cruz-Troca JJ, León-Muñoz LM, Guallar-Castillón P, Coca A et al. Achievement of cardiometabolic goals in aware hypertensive patients in Spain: a nationwide population-based study. Hypertension 2012;60:898-905.
5. Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials. J Hypertens 2014;32:2285-95.
6. O'Brien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G et al. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens 2013;31:1731-68.
7. Parati G, Stergiou G, O'Brien E, Asmar R, Beilin L, Bilo G et al. European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens 2014;32:1359-66.
8. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M et al. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension 1994;24:793-801.
9. Staessen JA, Thijs L, Fagard R, O'Brien ET, Clement D, de Leeuw PW et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA 1999;282:539-46.
10. Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med 2003;348:2407-15.
11. Kikuya M, Ohkubo T, Asayama K, Metoki H, Obara T, Saito S et al. Ambulatory blood pressure and 10-year risk of cardiovascular and noncardiovascular mortality: the Ohasama study. Hypertension 2005;45:240-5.
12. Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation 2005;111:1777-83.
13. Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension 2005;46:156-61.
14. Hansen TW, Kikuya M, Thijs L, Björklund-Bodegård K, Kuznetsova T, Ohkubo T et al. IDACO Investigators. Prognostic superiority of daytime ambulatory over conventional blood pressure in four populations: a meta-analysis of 7, 030 individuals. J Hypertens 2007;25:1554-64.
15. de la Sierra A, Banegas JR, Segura J, Gorostidi M, Ruilope LM; on behalf of the CARDIORISC Event Investigators. Ambulatory blood pressure monitoring and development of cardiovascular events in high-risk patients included in the Spanish ABPM registry: the CARDIORISC Event study. J Hypertens 2012;30:713-9.
16. Lovibond K, Jowett S, Barton P, Caulfield M, Heneghan C, Hobbs FD et al. Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study. Lancet 2011;378:1219-30.
17. Banegas JR, Segura J, Sobrino J, Rodríguez-Artalejo F, de la Sierra A, de la Cruz JJ et al. Effectiveness of blood pressure control outside the medical setting. Hypertension 2007;49:62-8.
18. Vinyoles E, Felip A, Pujol E, de la Sierra A, Durà R, del Rey RH et al. Clinical characteristics of isolated clinic hypertension. J Hypertens 2008;26:438-45.
19. Banegas JR, Ruilope LM, de la Sierra A, de la Cruz JJ, Gorostidi M, Segura J et al. High prevalence of masked uncontrolled hypertension (MUCH) in people with treated hypertension. Eur Heart J 2014;35:3304-12.
20. Banegas JR, Segura J, de la Sierra A, Gorostidi M, Rodríguez-Artalejo F, Sobrino J et al. Gender differences in office and ambulatory control of hypertension. Am J Med 2008;121:1078-84.
21. Banegas JR, de la Sierra A, Segura J, Gorostidi M, de la Cruz J, Rodríguez-Artalejo F et al. Control of hypertension in coronary heart disease. Int J Cardiol 2009;134:245-7.
22. Llisterri JL, Alonso FJ, Gorostidi M, Sierra C, de la Sierra A, Banegas JR et al. Sociedad Española de Hipertensión - Liga Española para la Lucha contra la Hipertensión Arterial (SEH-LELHA). Differences between office and ambulatory control of hypertension in very elderly patients. The CARDIORISC - MAPAPRES project. Med Clin (Barc) 2009;133:769-76 [article in Spanish].
23. de la Sierra A, Segura J, Banegas JR, Gorostidi M, de la Cruz JJ, Armario P et al. Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension 2011;57:898-902.
24. Gorostidi M, de la Sierra A, González-Albarrán O, Segura J, de la Cruz JJ, Vinyoles E et al. Abnormalities in ambulatory blood pressure monitoring in hypertensive patients with diabetes. Hypertens Res 2011;34:1185-9.
25. Gorostidi M, Sarafidis PA, de la Sierra A, Segura J, de la Cruz JJ, Banegas JR et al. Differences between office and 24-hour blood pressure control in hypertensive patients with CKD: a 5, 693-patient cross-sectional analysis from Spain. Am J Kidney Dis 2013;62:285-94.
26. Bobrie G, Clerson P, Ménard J, Postel-Vinay N, Chatellier G, Plouin PF. Masked hypertension: a systematic review. J Hypertens 2008;26:1715-25.
27. Mancia G, Bombelli M, Seravalle G, Grassi G. Diagnosis and management of patients with white-coat and masked hypertension. Nat Rev Cardiol 2011;8:686-93.
28. Franklin SS, Thijs L, Hansen TW, Li Y, Boggia J, Kikuya M et al. International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes Investigators. Significance of white-coat hypertension in older persons with isolated systolic hypertension: a meta-analysis using the International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes population. Hypertension 2012;59:564-71.
29. Gorostidi M, Vinyoles E, Banegas JR, de la Sierra A. Prevalence of white-coat and masked hypertension in national and international registries. Hypertens Res 2015;38:1-7.
30. National Institute for Health and Clinical Excellence (NICE). Hypertension. The clinical management of primary hypertension in adults. Clinical Guideline 127. 2011. Available at: www.nice.org.uk/guidance/CG127.
31. Moser M, Setaro JF. Resistant or difficult-to-control hypertension. N Engl J Med 2006;355:385-92.
32. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD et al. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation 2008;117:e510-26.
33. Gorostidi M, Sobrino J, Segura J, Sierra C, de la Sierra A, Hernandez del Rey R et al. Ambulatory blood pressure monitoring in hypertensive patients with high cardiovascular risk: a cross-sectional analysis of a 20 000-patient database in Spain. J Hypertens 2007;25:977-84.
34. Egan BM. Achievement of cardiometabolic goals in aware hypertensive patients in Spain: implications for population health. Hypertension 2012;60:891-3.
35. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA 2010;303:2043-50.